Newsroom

Categories: Diagnostics & Hospital Laboratory, Drug Discovery & Development, Clinical Research & Trials, Clinical Diagnostics, biopharma

CellCarta Establishes Strategic Partnership with Waters to Advance Companion Diagnostics Development

October 5, 2026

Categories: Diagnostics & Hospital Laboratory, Clinical Research & Trials, biopharma, Digital Pathology, AI

CellCarta and Imagene AI Expand Collaboration to Validate, Deploy and Scale AI-Powered Biomarker and Companion Diagnostic Programs Across Drug Development

October 1, 2026

Categories: biopharma, Digital Pathology, AI

CellCarta Launches Digital Pathology and AI Consortium to Accelerate Platform-Agnostic Biomarker Innovation Across Drug Development

July 15, 2026

Categories: Omics & Genetics, Biotechnology, Drug Discovery & Development, biopharma

Alithea Genomics Launches Early Access Program for MERCURIUS™ 1536 DRUG-seq, Bringing Transcriptomics to Compound Screening Scale

June 16, 2026

Categories: Corporate, Finance & Investor, Clinical Diagnostics, biopharma

Leica Biosystems and CellCarta expand collaborative companion diagnostic development model to accelerate commercialization globally

June 1, 2026

Categories: Research, Corporate, Finance & Investor, biopharma

GenNext and Agilent unveil groundbreaking technology integration to accelerate high-value decision making in biopharmaceutical research

September 11, 2024

Categories: General Laboratory, biopharma

Synexa Life Sciences expands biomarker discovery capabilities with the addition of Olink® target platform

March 4, 2024

Categories: Biotechnology, Drug Discovery & Development, biopharma

GenNext® Technologies announces partnership with Emery Pharma on full-solution biopharmaceutical protein footprinting services

May 17, 2023

Categories: Analytical Chemistry, biopharma

New application-specific LC system to precisely deliver high-purity products or isolation of contaminants

October 10, 2022